Core Biogenesis

Core Biogenesis is an innovative biotech firm pioneering a plant-based bioproduction platform for recombinant proteins and peptides. The company targets two primary markets: the Life Science industry for regenerative medicine applications and the Beauty & Wellness industry for advanced skincare. Its core technological advantage lies in the precise targeting of proteins to plant oleosomes, which improves stability and aims to overcome traditional production bottlenecks. As a private, early-stage company, Core Biogenesis is positioned to capitalize on the growing demand for sustainable and scalable biologics manufacturing.

Proprietary plant-based bioproduction platform that targets recombinant proteins and peptides to plant oleosomes to improve stability, yield, and purity. Offers a sustainable and scalable alternative to traditional mammalian or microbial systems.

Core Biogenesis competes with traditional recombinant protein producers using CHO cells, E. coli, and yeast, as well as other novel platform companies exploring algae, moss, or other plant systems. In skincare, it competes with synthetic peptide producers and companies extracting bioactives from traditional sources.